2018-OJS76-169070-sv

I.1.

Namn och adresser
Officiellt namn: Karolinska Institutet

Nationellt registreringsnummer: 202100-2973

Postadress: Universitetsförvaltningen

Ort: Stockholm

Nuts-kod: SE11 Stockholm

Postnummer: 171 77

Land: Sverige

Kontaktperson: Åsa Bergström

E-post: asa.bergstrom@ki.se

Internetadress(er):

Allmän adress: http://www.ki.se

I.4.

Typ av upphandlande myndighet
Departement eller annan central, regional eller lokal statlig myndighet

I.5.

Huvudsaklig verksamhet
Utbildning

II.1.

Upphandlingens omfattning

II.1.1.

Benämning på upphandlingen

RNA/DNA solid phase synthesizer

Referensnummer: 2-5806/2017

II.1.2.

Huvudsaklig CPV-kod
38000000 Laboratorieutrustning, optisk utrustning och precisionsutrustning (exkl. glas)

II.1.3.

Typ av kontrakt
Varor

II.1.4.

Kort beskrivning

A Solid phase synthesizer.

II.1.6.

Information om delar
Kontraktet är uppdelat i flera delar: nej

II.2.

Beskrivning

II.2.2.

Ytterligare CPV-kod(er)
38900000 Diverse mät- och provinstrument

II.2.3.

Plats för utförande

Nuts-kod: SE11 Stockholm

II.2.4.

Beskrivning av upphandlingen

A Solid phase synthesizer.

Invitation to tender.

Karolinska Institutet, hereinafter called KI, invites companies, hereinafter called the Tenderers, to submit tenders concerning a RNA/DNA solid phase synthesizer with platform specific reagents, accessories, service, support, upgrades and updates. Signed agreement is to be used by the Department of Medical Biochemistry and Biophysics at KI, hereinafter called the Person/Office making a call-off order.

Requested product and service.

The estimated value of one RNA/DNA solid phase synthesizer as described in the procurement documents is 1 000 000 SEK.

The value for the future purchases of the platform specific reagents, accessories, service, support, upgrades and updates is not possible to estimate.

Please note that the statistics provided here are for information purposes only. The future demand may exceed or fall below the amounts indicated here. KI does not offer any volume guarantee; rather, the Tenderer undertakes to fulfill the actual demand that arises for the platform specific reagents, accessories, service, support, upgrades and updates.

Agreement term.

The agreement shall become effective when the parties, KI and the chosen supplier, have signed the contract. The exact start date shall be determined upon signing of the agreement.

The agreement shall be valid for four (4) years after the contract has been signed.

Contents.

The tender request documentation consists of the following document parts:

1. Invitation to tender;

2. Administrative rules;

3. Evaluation and Qualification;

4. Supplier qualification;

5. Technical requirements;

6. Commercial terms and conditions.

Additional information published during the procurement procedure is considered to be part of the procurement documents.The Tenderer is responsible for acquiring all of the procurement documents.

Procurement authority.

Karolinska InstitutetReg. no: 202100-2973Visiting address:Nobels väg 6171 77 Stockholm.

Reception in Aula Medica is staffed on weekdays 8:00 – 17:00.

Contact person during the procurement process.

Any questions are to be asked via TendSign.

Contact person:

Åsa BergströmPurchasing and Procurement unite-mail: Asa.Bergstrom@ki.se

Procurement procedure.

The procurement is carried out as an open procedure according to Chapter 6, § 2 of the Swedish Public Procurement Act (2016: 1145) (LOU).

For more information on procurement procedures, see upphandlingsmyndigheten.se/upphandla/om-upphandlingsreglerna/Upphandlingsforfaranden.

Tender’s period of validity.

The tender must be valid until 8.3.2018. If necessary, KI may request an extension of the tender validity period, for example, if the procurement process or the contract award decision is appealed in court.

Compensation.

KI shall reject all Tenderer’s claims for compensation for the work performed during participation in the procurement process.

Description.

Karolinska Institutet (KI) will acquire a RNA/DNA solid phase synthesizer which is needed for large scale RNA sample production for RNA structural biology (~1 μmol scale, several 1 umol scale synthesis over short period of time, every few weeks) with platform specific accessories, reagents, service, support, upgrades and updates to the RNA/DNA solid phase synthesizer when there is no possibility to acquire these from other suppliers for compatibility reasons.

II.2.5.

Tilldelningskriterier

Pris

II.2.11.

Information om optioner
Option: nej

II.2.13.

Information om EU-medel
Kontraktet är knutet till projekt och/eller program som finansieras med EU-medel: nej

II.2.14.

Kompletterande upplysningar

IV.1.

Beskrivning

IV.1.1.

Typ av förfarande
Öppet förfarande

IV.1.3.

Information om ramavtal eller dynamiskt inköpssystem

IV.1.8.

Information om avtalet om offentlig upphandling
Upphandlingen omfattas av avtalet om offentlig upphandling: ja

IV.2.

Administrativ information

IV.2.8.

Information om avslutande av det dynamiska inköpssystemet

IV.2.9.

Information om avslutande av anbudsinfordran i form av ett förhandsmeddelande

Ett kontrakt/delkontrakt tilldelas: nej

V.1.

Upplysningar om utebliven tilldelning
Kontraktet/delen har inte tilldelats
Andra orsaker (avbrutet förfarande)

VI.3.

Kompletterande upplysningar

Motivation for cancelling.

There was no valid tenders and the Tenderer that submitted a tender cannot fulfill the obligatory demands.

Visma notice: https://opic.com/id/afadocbflu

VI.4.

Överprövningsförfaranden

VI.4.1.

Behörigt organ vid överprövning
Officiellt namn: Förvaltningsrätten

Ort: Stockholm

Land: Sverige

VI.5.

Datum då meddelandet sänts
18/04/2018